OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine
Takashi Hamazaki, Nihal El Rouby, Natalie C. Fredette, et al.
Stem Cells (2017) Vol. 35, Iss. 3, pp. 545-550
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Mechanisms of tissue and cell-type specificity in heritable traits and diseases
Idan Hekselman, Esti Yeger‐Lotem
Nature Reviews Genetics (2020) Vol. 21, Iss. 3, pp. 137-150
Closed Access | Times Cited: 147

Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
Pranav Machiraju, Steven C. Greenway
World Journal of Stem Cells (2019) Vol. 11, Iss. 1, pp. 33-43
Open Access | Times Cited: 99

Induced pluripotent stem cells for neural drug discovery
Atena Farkhondeh, Rong Li, Kirill Gorshkov, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 4, pp. 992-999
Open Access | Times Cited: 78

CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons
Gong‐Her Wu, Charlene Smith-Geater, Jesús G. Galaz-Montoya, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40

Stem cell therapeutics and gene therapy for neurologic disorders
Kevin S. Chen, Emily J. Koubek, Stacey A. Sakowski, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00427-e00427
Open Access | Times Cited: 10

hiPSCs Derived Cardiac Cells for Drug and Toxicity Screening and Disease Modeling: What Micro- Electrode-Array Analyses Can Tell Us
Sophie Kussauer, Robert David, Heiko Lemcke
Cells (2019) Vol. 8, Iss. 11, pp. 1331-1331
Open Access | Times Cited: 69

Adipose-derived stem cell therapies for bone regeneration
Marta Barba, Giuseppe Di Taranto, Wanda Lattanzi
Expert Opinion on Biological Therapy (2017) Vol. 17, Iss. 6, pp. 677-689
Open Access | Times Cited: 60

From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases
Matteo Bordoni, Federica Rey, Valentina Fantini, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3972-3972
Open Access | Times Cited: 57

Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
Ali Zarei, Vahid Razban, Seyed Ebrahim Hosseini, et al.
The Journal of Gene Medicine (2019) Vol. 21, Iss. 4
Closed Access | Times Cited: 51

A logic-incorporated gene regulatory network deciphers principles in cell fate decisions
Gang Xue, X. Zhang, Wanqi Li, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 6

Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases
Nona Farbehi, Drew Neavin, Anna Cuomo, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 758-766
Closed Access | Times Cited: 5

Scalable culture of human induced pluripotent cells on microcarriers under xeno‐free conditions using single‐use vertical‐wheel™ bioreactors
Carlos A. V. Rodrigues, Teresa P. Silva, Diogo E.S. Nogueira, et al.
Journal of Chemical Technology & Biotechnology (2018) Vol. 93, Iss. 12, pp. 3597-3606
Closed Access | Times Cited: 40

Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy
Wei Zheng, Qian Li, Chao Zhao, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 40

Precision medicine journey through omics approach
Mandana Hasanzad, Negar Sarhangi, Sima Ehsani Chimeh, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 21, Iss. 1, pp. 881-888
Open Access | Times Cited: 29

iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine
Shashank Pandey, Michal Jirásko, Jan Lochman, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1485-1485
Open Access | Times Cited: 21

Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases
Glen Lester Sequiera, Abhay Srivastava, Niketa Sareen, et al.
Science Advances (2022) Vol. 8, Iss. 14
Open Access | Times Cited: 19

Genetic dissection of the pluripotent proteome through multi-omics data integration
Selcan Aydin, Duy T. Pham, Tian Zhang, et al.
Cell Genomics (2023) Vol. 3, Iss. 4, pp. 100283-100283
Open Access | Times Cited: 12

Biological basis of critical illness subclasses: from the bedside to the bench and back again
Joseph Stevens, Oğuzhan Tezel, Valentina Bonnefil, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 4

Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells
Daisuke Yoshinaga, Shiro Baba, Takeru Makiyama, et al.
Stem Cell Reports (2019) Vol. 13, Iss. 2, pp. 394-404
Open Access | Times Cited: 34

Reawakening the Developmental Origins of Cancer Through Transposable Elements
Chiemi F. Lynch‐Sutherland, Aniruddha Chatterjee, Peter A. Stockwell, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 32

Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking
Michael A. Lensink, Sarah N. Boers, Karin Jongsma, et al.
Journal of Cystic Fibrosis (2020) Vol. 20, Iss. 3, pp. 443-451
Open Access | Times Cited: 31

HiPS-Endothelial Cells Acquire Cardiac Endothelial Phenotype in Co-culture With hiPS-Cardiomyocytes
Emmi Helle, Minna Ampuja, Alexandra Dainis, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 27

The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration
Cristina Carresi, Miriam Scicchitano, Federica Scarano, et al.
Nutrients (2021) Vol. 13, Iss. 1, pp. 275-275
Open Access | Times Cited: 24

MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1
Mengge Wang, Hongtao Wang, Yuqi Wen, et al.
Stem Cell Research & Therapy (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 32

Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine
Domenico D’Amario, Aoife Gowran, Francesco Canonico, et al.
Journal of Clinical Medicine (2018) Vol. 7, Iss. 9, pp. 291-291
Open Access | Times Cited: 30

Page 1 - Next Page

Scroll to top